Protocol Section
The Protocol Section is one of the main sections in ClinicalTrials.gov data structure. It contains protocol-related information for clinical trials, including identification, status, design, eligibility, and other key details about how the trial is structured and conducted.
Protocol Section path is as follows:
Study -> Protocol Section -> Protocol Modules (Identification, Status, Design, Eligibility, etc.)
Protocol Section
Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-25 @ 1:46 AM
NCT ID:
NCT03813394
Description:
Individual patient data will be available, including data dictionaries, including all clinical data collected in the conduct of the trial in a deidentified format. Other documents available include the study protocol, statistical analysis plan, informed consent form and the clinical study report. This will be available beginning 3 months after article publication with no end date. Researchers whose proposed use of the data has been approved by an independent ethics review committee can access the data to achieve the aims in the proposal. Proposals should be directed to the corresponding author to provide data access following signing a data access agreement. The data will be made available by a link sent from the corresponding author to the requester.
Study:
NCT03813394
Study Brief:
Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC